Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Allogeneic Platelet-Rich Plasma: Is It Safe and Effective for Wound Repair?

Akbarzadeh S, McKenzie MB, Rahman MM, Cleland H

(2021), Eur Surg Res, 62(1), 1-9

DOI: 10.1159/000514223

Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis?

Lu P, Harms KA, Paul E, Bortz H, Lo C, Cleland H

(2021), J PLAST RECONSTR AES, 74(8), 1814-23

DOI: 10.1016/j.bjps.2020.12.011

Burn wound excision within 24 h: A 9-year review

Moussa A, Lo CH, Cleland H

(2021), Burns, 47(6), 1300-7

DOI: 10.1016/j.burns.2020.12.014

A platelet-derived hydrogel improves neovascularisation in full thickness wounds

Rahman MM, Garcia N, Loh YS, Marks DC, Banakh I, Jagadeesan P, Cameron NR, Yung-Chih C, Costa M, Peter K, Cleland H, Akbarzadeh S

(2021), Acta Biomater, 136, 199-209

DOI: 10.1016/j.actbio.2021.09.043

Association between gender and outcomes of acute burns patients

Perkins M, Abesamis GM, Cleland H, Gabbe BJ, Tracy LM

(2021), ANZ J Surg, 91(1), 83-8

DOI: 10.1111/ans.16426

Pain assessment following burn injury in Australia and New Zealand: Variation in practice and its association on in-hospital outcomes

Tracy LM, Cleland H, Cameron PA, Gabbe BJ

(2021), Australas Emerg Care, 24(1), 73-9

DOI: 10.1016/j.auec.2020.07.007

Improvement of Burn Scars Treated With Fractional Ablative CO2 Lasers-A Systematic Review and Meta-analysis Using the Vancouver Scar Scale

Mahar PD, Spinks AB, Cleland H, Bekhor P, Waibel JS, Lo C, Goodman G

(2021), J Burn Care Res, 42(2), 200-6

DOI: 10.1093/jbcr/iraa130

Iron Deficiency in PREVENTT

Keegan A, Crispin P, Ormerod A, Brown K, Akers C, King F

(2021), Lancet, 397(10275), 669

DOI: 10.1016/S0140-6736(21)00216-6

When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Haematology Patients

Batchelor R, Thomas C, Gardiner BJ, Lee SJ, Fleming S, Wei A, Coutsouvelis J, Ananda-Rajah M

(2021), OPEN FORUM INFECT DI, 8(7), ofab113

DOI: 10.1093/ofid/ofab113

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haematopoietic stem cell transplantation, 2021

Teh BW, Yeoh DK, Haeusler GM, Yannakou CK, Fleming S, Lindsay J, Slavin MA; Australasian Antifungal Guidelines Steering Committee

(2021), Intern Med J, 51 Suppl7, 67-88

DOI: 10.1111/imj.15588

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refrac tory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.

Pullarkat VA, Lacayo NJ, Jabbour E, Rubnitz JE, Bajel A, Laetsch TW, Leonard J, Colace SI, Khaw SL, Fleming SA, Mattison RJ, Norris R, Opferman JT, Roberts KG, Zhao Y, Qu C, Badawi M, Schmidt M, Tong B, Pesko JC, Sun Y, Ross JA, Vishwamitra D, Rosenwinkel L, Kim SY, Jacobson A, Mullighan CG, Alexander TB, Stock W

(2021), Cancer Discov, 11(6), 1140-53

DOI: 10.1158/2159-8290.CD-20-1465

Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Non-Interventional Study

Kenet G, Chen YC, Lowe G, Percy C, Tran H, von Drygalski A, Trossaërt M, Reding M, Oldenburg J, Mingot-Castellano ME, Park YS, Peyvandi F, Ozelo MC, Mahlangu J, Quinn J, Huang M, Reddy DB, Kim B

(2021), J Clin Med, 10(24), 5959

DOI: 10.3390/jcm10245959

Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors- A non-interventional study

Oldenburg J, Tran H, Peyvandi F, Núñez R, Trask P, Chebon S, Mahlangu JN, Lehle M, Jiménez-Yuste V, von Mackensen S

(2021), Haemophilia, 27(3), 398-407

DOI: 10.1111/hae.14270

Australian and New Zealand approach to diagnosis and management of vaccine-induced thrombosis and thrombocytopenia

Chen VM, Curnow JL, Tran HA, Choi PY

(2021), MED J AUSTRALIA, 215(6), 245-9.e1

DOI: 10.5694/mja2.51229

Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo

Draxler DF, Zahra S, Goncalves I, Tran H, Hanafi G, Ho H, Keragala CB, Ilich A, Key NS, Myles PS, Medcalf RL

(2021), BLOOD COAGUL FIBRIN, 32(3), 172-9

DOI: 10.1097/MBC.0000000000001008

Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series

Campbell S, Mason J, Prasad R, Ambrose H, Hunt S, Tran H

(2021), Intern Med J, 51(2), 215-9

DOI: 10.1111/imj.14773

The first known case of vaccine-induced thrombotic thrombocytopenia in Australia

Hocking J, Chunilal SD, Chen VM, Brighton T, Nguyen J, Tan J, Ting SB, Tran H

(2021), MED J AUSTRALIA, 215(1), 19-20e.1

DOI: 10.5694/mja2.51135

Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia

Gordon SF, Clothier HJ, Morgan H, Buttery JP, Phuong LK, Monagle P, Chunilal S, Wood EM, Tran H, Szer J, Crawford NW; SAEFVIC and VicSIS investigators

(2021), Vaccine, 39(48), 7052-7

DOI: 10.1016/j.vaccine.2021.10.030

Upper extremity deep vein thrombosis: current knowledge and future directions

Yuen HLA, Tran H, Chunilal S

(2021), Semin Thromb Hemost, 47(6), 677-91

DOI: 10.1055/s-0041-1725116

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Chang CC, Hall V, Cooper C, Grigoriadis G, Beardsley J, Sorrell TC, Heath CH; and the Australasian Antifungal Guidelines Steering Committee.

(2021), Intern Med J, 51 Suppl7, 118-42

DOI: 10.1111/imj.15590

179 180 181 182 183